11-747577-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_ModerateBP7BS1_Supporting
The NM_006755.2(TALDO1):c.96C>T(p.His32=) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000731 in 1,573,420 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006755.2 splice_region, synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TALDO1 | NM_006755.2 | c.96C>T | p.His32= | splice_region_variant, synonymous_variant | 1/8 | ENST00000319006.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TALDO1 | ENST00000319006.8 | c.96C>T | p.His32= | splice_region_variant, synonymous_variant | 1/8 | 1 | NM_006755.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000283 AC: 43AN: 152212Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000322 AC: 6AN: 186444Hom.: 0 AF XY: 0.0000391 AC XY: 4AN XY: 102298
GnomAD4 exome AF: 0.0000479 AC: 68AN: 1421100Hom.: 1 Cov.: 31 AF XY: 0.0000440 AC XY: 31AN XY: 705034
GnomAD4 genome AF: 0.000309 AC: 47AN: 152320Hom.: 1 Cov.: 34 AF XY: 0.000282 AC XY: 21AN XY: 74488
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 12, 2022 | This sequence change affects codon 32 of the TALDO1 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the TALDO1 protein. It affects a nucleotide within the consensus splice site. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with TALDO1-related conditions. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
TALDO1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 15, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at